Merck Insomnia Drug Safe Only in Low Doses

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Are Cloud Robotics Are a Game-Changer?
05:21 - “The Industries of the Future” Author Alec Ross discusses cloud robotics and the future of robot technology on “Bloomberg West.” (Source: Bloomberg)
  • Is There a Tech Talent Shortage in Silicon Valley?
  • Blackberry Cuts Jobs in Push to Profit
  • Bloomberg Businessweek: The Female Solidarity